Order Article Reprints

Klinger D, Hill BL, Barda N, Halperin E, Gofrit ON, Greenblatt CL, Rappoport N, Linial M, Bercovier H. Bladder Cancer Immunotherapy by BCG Is Associated with a Significantly Reduced Risk of Alzheimer’s Disease and Parkinson’s Disease. Vaccines. 2021; 9(5):491. https://doi.org/10.3390/vaccines9050491

Klinger, Danielle, Brian L. Hill, Noam Barda, Eran Halperin, Ofer N. Gofrit, Charles L. Greenblatt, Nadav Rappoport, Michal Linial, and Hervé Bercovier. 2021. "Bladder Cancer Immunotherapy by BCG Is Associated with a Significantly Reduced Risk of Alzheimer’s Disease and Parkinson’s Disease" Vaccines 9, no. 5: 491. https://doi.org/10.3390/vaccines9050491

Klinger, D., Hill, B. L., Barda, N., Halperin, E., Gofrit, O. N., Greenblatt, C. L., Rappoport, N., Linial, M., & Bercovier, H. (2021). Bladder Cancer Immunotherapy by BCG Is Associated with a Significantly Reduced Risk of Alzheimer’s Disease and Parkinson’s Disease. Vaccines, 9(5), 491. https://doi.org/10.3390/vaccines9050491